PAYRX Trademark

Trademark Overview

On Monday, November 1, 2021, a trademark application was filed for PAYRX with the United States Patent and Trademark Office. The USPTO has given the PAYRX trademark a serial number of 97978679. The federal status of this trademark filing is SU - REGISTRATION REVIEW COMPLETE as of Tuesday, October 15, 2024. This trademark is owned by PayRx, Inc.. The PAYRX trademark is filed in the Insurance & Financial Services category with the following description:

Financial risk management services, namely, risk financing services for medical therapies and related expenses; Advisory and consultation services to help manage costs of advanced medical therapies; Commercial lending services.
payrx

General Information

Serial Number97978679
Word MarkPAYRX
Filing DateMonday, November 1, 2021
Status819 - SU - REGISTRATION REVIEW COMPLETE
Status DateTuesday, October 15, 2024
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, May 16, 2023

Trademark Statements

Pseudo MarkPAY RX
Goods and ServicesFinancial risk management services, namely, risk financing services for medical therapies and related expenses; Advisory and consultation services to help manage costs of advanced medical therapies; Commercial lending services.

Classification Information

International Class036 - Insurance; financial affairs; monetary affairs; real estate affairs.
US Class Codes100, 101, 102
Class Status Code6 - Active
Class Status DateThursday, November 11, 2021
Primary Code036
First Use Anywhere DateThursday, October 12, 2023
First Use In Commerce DateThursday, October 12, 2023

Trademark Owner History

Party NamePayRx, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressNew York, NY 10173
Party NamePayRx, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressNew York, NY 10173

Trademark Events

Event DateEvent Description
Friday, September 2, 2022NON-FINAL ACTION WRITTEN
Friday, September 2, 2022NON-FINAL ACTION E-MAILED
Thursday, March 2, 2023TEAS RESPONSE TO OFFICE ACTION RECEIVED
Thursday, March 2, 2023CORRESPONDENCE RECEIVED IN LAW OFFICE
Thursday, November 4, 2021NEW APPLICATION ENTERED
Wednesday, August 10, 2022ASSIGNED TO EXAMINER
Thursday, November 11, 2021NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Friday, September 2, 2022NOTIFICATION OF NON-FINAL ACTION E-MAILED
Thursday, March 2, 2023TEAS/EMAIL CORRESPONDENCE ENTERED
Friday, April 7, 2023APPROVED FOR PUB - PRINCIPAL REGISTER
Tuesday, May 16, 2023PUBLISHED FOR OPPOSITION
Tuesday, May 16, 2023OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, July 11, 2023NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Thursday, January 11, 2024SOU TEAS EXTENSION RECEIVED
Thursday, January 11, 2024SOU EXTENSION 1 GRANTED
Thursday, January 11, 2024SOU EXTENSION 1 FILED
Saturday, January 13, 2024NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, June 24, 2024USE AMENDMENT FILED
Monday, June 24, 2024TEAS STATEMENT OF USE RECEIVED
Monday, June 24, 2024SOU TEAS EXTENSION RECEIVED
Friday, August 16, 2024CASE ASSIGNED TO INTENT TO USE PARALEGAL
Thursday, August 22, 2024DIVISIONAL PROCESSING COMPLETE
Thursday, August 22, 2024STATEMENT OF USE PROCESSING COMPLETE
Thursday, August 22, 2024DIVISIONAL REQUEST RECEIVED
Wednesday, April 26, 2023NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Monday, June 24, 2024TEAS REQUEST TO DIVIDE RECEIVED
Tuesday, October 15, 2024ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Tuesday, October 15, 2024NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED

Related Keywords

payrx services medical risk therapies help costs manage advanced lending commercial